Calamos Wealth Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Calamos Wealth Management LLC

  • $1.93 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 13, 2018
SELL
$315.82 - $393.78 $617,112 - $769,446
-1,954 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $164,969 - $216,177
460 Added 30.79%
1,954 $735,000
Q3 2017

Oct 25, 2017
BUY
$431.38 - $504.0 $644,481 - $752,976
1,494
1,494 $668,000

Others Institutions Holding REGN

# of Institutions
1,490
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.44M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Calamos Wealth Management LLC Portfolio

Follow Calamos Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email